Holen Sie sich die Stockscreener-App
2.40
7.51%
-0.195
Schlusskurs vom Vortag:
$2.595
Offen:
$2.62
24-Stunden-Volumen:
318.13K
Relative Volume:
1.16
Marktkapitalisierung:
$66.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.14M
KGV:
-2.6087
EPS:
-0.92
Netto-Cashflow:
$-12.64M
1W Leistung:
-11.76%
1M Leistung:
-8.40%
6M Leistung:
+19.40%
1J Leistung:
+17.65%
1-Tages-Spanne:
$2.35
$2.67
1-Wochen-Bereich:
$2.35
$2.95
52-Wochen-Spanne:
$1.26
$3.12
Immix Biopharma Inc Stock (IMMX) Company Profile
Firmenname
Immix Biopharma Inc
Sektor
Branche
Telefon
(888) 958-1084
Adresse
11400 WEST OLYMPIC BLVD., LOS ANGELES
Vergleichen Sie IMMX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMMX
Immix Biopharma Inc
|
2.3801 | 79.45M | 0 | -14.14M | -12.64M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
377.00 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.82 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
427.60 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
668.59 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
294.77 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Immix Biopharma Inc Aktie (IMMX) Neueste Nachrichten
Visual analytics tools that track Immix Biopharma Inc. performanceFree Community Verified Stock Suggestions - Newser
ImmixBio plans to partner out CAR-T therapy for other diseases By Investing.com - Investing.com South Africa
Immix Biopharma Announces Other Serious Diseases Strategy - GlobeNewswire
Immix Biopharma, Inc. Announces Other Serious Diseases Strategy - MarketScreener
Pricing Power vs. Volume Pressure: What's Driving PepsiCo Now? - The Globe and Mail
Quantitative breakdown of Immix Biopharma Inc. recent moveFree AI Powered High Return Stock Calls - Newser
Can machine learning forecast Immix Biopharma Inc. recoveryFree Technical Stock Breakout Predictions - Newser
Market reaction to Immix Biopharma Inc.’s recent newsFree Smart Allocation Stock Pick Insights - Newser
Real time alert setup for Immix Biopharma Inc. performanceFree News Based Entry Opportunity Alerts - Newser
How moving averages guide Immix Biopharma Inc. tradingChart Driven Entry Timing for Swing Trades - Newser
Live market analysis of Immix Biopharma Inc.Free Fast Entry High Potential Stock Alerts - Newser
Can Traders Expect Breakout From Immix Biopharma Inc. This WeekSecure Capital Picks With Upside Potential Tracked - metal.it
Relative strength of Immix Biopharma Inc. in sector analysisFree Oversold Recovery Opportunity Stocks - Newser
Why Immix Biopharma Inc. stock attracts strong analyst attentionSmart Trend Analysis With Buy Point Cues - Newser
Will Immix Biopharma Inc. Stock Benefit from AI and Green Energy TrendsShort-Term AI-Based Stock Price Forecast - Newser
How many analysts rate Immix Biopharma Inc. as a “Buy”Turn market volatility into profit opportunities - Jammu Links News
Should I hold or sell Immix Biopharma Inc. stock in 2025Build wealth steadily with proven stock picks - Jammu Links News
What are analysts’ price targets for Immix Biopharma Inc. in the next 12 monthsCapitalize on fast-growing investment opportunities - Jammu Links News
What institutional investors are buying Immix Biopharma Inc. stockLightning-fast growth - Jammu Links News
What are the technical indicators suggesting about Immix Biopharma Inc.Achieve consistent profits with smart trading - Jammu Links News
When is Immix Biopharma Inc. stock expected to show significant growth - Jammu Links News
Immix Biopharma Inc. Stock Analysis and ForecastSuperior returns - Jammu Links News
How does Immix Biopharma Inc. generate profit in a changing economyAchieve breakthrough profits with smart strategies - Jammu Links News
Is it the right time to buy Immix Biopharma Inc. stockFree Stock Chart Pattern Guide - Jammu Links News
Real time social sentiment graph for Immix Biopharma Inc.Free Consistent Income Focused Trade List - newser.com
How does Immix Biopharma Inc. compare to its industry peersTurbocharged investment results - Jammu Links News
Is Immix Biopharma Inc. a good long term investmentDiscover market opportunities others miss - Jammu Links News
How volatile is Immix Biopharma Inc. stock compared to the marketCapitalize on emerging market sectors - Jammu Links News
What makes Immix Biopharma Inc. stock price move sharplyBuild a diversified portfolio for risk mitigation - Jammu Links News
Is Immix Biopharma Inc. Stock a Smart Buy in 2025 Investment Analysis InsideHigh Return Stock Focus With Safety Emphasized - beatles.ru
How strong is Immix Biopharma Inc. company’s balance sheetExpert Picks Entry Points For 2025 - Jammu Links News
Will Hims & Hers Fall Along With Novo Nordisk? - The Globe and Mail
Take a Bite of Apple's Solid Q3 Earnings With These ETFs - The Globe and Mail
Is Immix Biopharma Inc. a growth stock or a value stockSwing Trade Forecasts For Smart Trading - Jammu Links News
What are Immix Biopharma Inc. company’s key revenue driversPost Market Recommendation With High Returns - Jammu Links News
Using Ichimoku Cloud for Immix Biopharma Inc. technicalsFree Fast Return Equity Trade Forecast - Newser
Surge Energy Boosts 2025 Production Guidance and Cuts Capital Budget - The Globe and Mail
Volume Profile Shows Strong Base for Immix Biopharma Inc.Stock Market Entry Timing Signals Revealed - metal.it
Finanzdaten der Immix Biopharma Inc-Aktie (IMMX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Immix Biopharma Inc-Aktie (IMMX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Morris Gabriel S | CFO |
Jun 18 '25 |
Buy |
2.28 |
2,225 |
5,071 |
288,059 |
| Hsu Jason | Director |
Dec 23 '24 |
Buy |
2.19 |
40,000 |
87,680 |
893,000 |
| Hsu Jason | Director |
Dec 20 '24 |
Buy |
2.17 |
7,700 |
16,678 |
853,000 |
| Hsu Jason | Director |
Aug 21 '24 |
Buy |
2.23 |
15,000 |
33,390 |
837,200 |
| Hsu Jason | Director |
Aug 22 '24 |
Buy |
2.25 |
8,100 |
18,233 |
845,300 |
| Ng Carey | Director |
Aug 16 '24 |
Buy |
1.86 |
10,000 |
18,600 |
20,000 |
0.53%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):